Heart disease remains the No. 1 global cause of death with 17.3 million deaths each year, according to “Heart Disease and Stroke Statistics — 2015 Update: A Report From the American Heart Association.” That number is expected to rise to more than 23.6 million by 2030, the report found.
A minuscule number of these patients get defibrillation in-time and survive. The time between the cardiac arrest and defibrillation of the patient is the most crucial factor for achieving higher survival rates.
FlyPulse, a Sweden based company, is building the next-generation technology, based on their specially-designed drones, to address this challenge. LifeDrone AED is a transportation drone, equipped with an automated external defibrillator (AED) — a portable electronic device that automatically diagnoses the life threatening cardiac arrhythmias and is able to treat them through defibrillation, the application of electrical therapy.